US biotechnology firm Moderna on Monday said lab studies showed its COVID-19 vaccine would remain protective against variants of the coronavirus first identified in the United […]
While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development […]
The medical community appears to be split over whether the UK has made the right decision in delaying the second Pfizer BioNTech vaccine dose from three […]
Ten million deaths per year by 2050 related to antimicrobial resistance—that’s what a large British study, conducted in 2014, predicts if the current trend continues. Despite […]